利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

116 条记录 (耗时 0.032 秒)

    Resist composition, method for forming resist pattern, novel compound and acid generator
    3.
    发明专利
    Resist composition, method for forming resist pattern, novel compound and acid generator 有权
    抗蚀剂组合物，形成抗蚀剂图案，新型化合物和酸产生剂的方法

    公开(公告)号：JP2012242799A

    公开(公告)日：2012-12-10

    申请号：JP2011116131

    申请日：2011-05-24

    申请人： Tokyo Ohka Kogyo Co Ltd ,  東京応化工業株式会社

    发明人： KAWAKAMI AKINARI ,  UTSUMI YOSHIYUKI

    IPC分类号： G03F7/004 ,  C07D313/06 ,  C09K3/00 ,  G03F7/039 ,  H01L21/027

    摘要： PROBLEM TO BE SOLVED: To provide a resist composition excellent in lithographic characteristics and a pattern profile, a method for forming a resist pattern using the resist composition, a novel compound useful as an acid generator for the resist composition, and an acid generator.SOLUTION: The resist composition includes: a base component (A) the solubility of which with a developing solution changes by an action of an acid; and an acid generator component (B) which generates an acid by exposure, the acid generator component (B) including an acid generator (B1) having a group expressed by the formula (b1-1) in a cationic moiety. In the formula, R' represents a 1-6C alkyl group, 1-6C alkoxy group, 1-6C halogenated alkyl group, halogen atom, hydroxy group, -COOR", -OC(=O)R", hydroxyalkyl group or cyano group, R" represents a hydrogen atom or an alkyl group, and p represents an integer of 0 to 4.

    摘要翻译： 要解决的问题：提供光刻特性和图案轮廓优异的抗蚀剂组合物，使用该抗蚀剂组合物形成抗蚀剂图案的方法，可用作抗蚀剂组合物的酸发生剂的新型化合物和酸 发电机。 抗蚀剂组合物包括：其与显影液的溶解度通过酸的作用而改变的碱成分（A） 和通过暴露产生酸的酸发生剂组分（B），所述酸产生剂组分（B）在阳离子部分包含由式（b1-1）表示的基团的酸产生剂（B1）。 式中，R'表示1-6C烷基，1-6C烷氧基，1-6C卤代烷基，卤素原子，羟基，-COOR“，-OC（= O）R”，羟基烷基或氰基 基团，R“表示氢原子或烷基，p表示0〜4的整数。权利要求（C）2013，JPO＆INPIT

    Agent for treatment of disease caused e.g. by nerve cell degeneration and containing salvianolic acid b, or the like
    5.
    发明专利
    Agent for treatment of disease caused e.g. by nerve cell degeneration and containing salvianolic acid b, or the like 审中-公开
    治疗疾病的药剂E.G. 由神经细胞变性和含有乙酰胆碱B或类似物

    公开(公告)号：JP2006151835A

    公开(公告)日：2006-06-15

    申请号：JP2004341367

    申请日：2004-11-26

    申请人： Torao Ishida ,  Suzuka Univ Of Medical Science ,  学校法人鈴鹿医療科学大学 ,  寅夫 石田

    发明人： ISHIDA TORAO ,  KAKU RIHEI

    IPC分类号： A61K31/34 ,  A61K31/216 ,  A61K31/335 ,  A61K31/357 ,  A61P25/00 ,  A61P43/00 ,  C07D307/80 ,  C07D307/84 ,  C07D313/06 ,  C07D313/14 ,  C07D319/20 ,  C12N5/07 ,  C12N5/074 ,  C12N5/0789 ,  C12N5/0797

    摘要： PROBLEM TO BE SOLVED: To provide a new agent for the treatment of diseases caused by nerve cell degeneration, etc., its active component, a method for the preparation of the active component, and a substance and technique necessary for the method. SOLUTION: It has been found that a compound selected from salvianolic acid B, its optical or geometrical isomer having an action similar to salvianolic acid B, their prodrugs, pharmacologically permissible salt and hydrate of the above compounds and their prodrugs has an action to effect the proliferation and/or differentiation of a neural stem cell while protecting the neural stem cell or its differentiated cell. The finding induces the development of an agent acting on the neural cell and containing these substances as active components, a method for acting on the neural cell by using the acting agent, a method for the preparation of liquid containing neural cell and produced by using the acting method, a liquid containing neural cell and produced by using the preparation method, and an agent for the treatment of diseases caused e.g. by neural cell degeneration by using the acting agent and/or the liquid containing the neural cell as active components. COPYRIGHT: (C)2006,JPO&NCIPI

    摘要翻译： 待解决的问题：为了提供治疗由神经细胞变性等引起的疾病的新药，其活性成分，制备活性成分的方法以及该方法所需的物质和技术 。 解决方案：已经发现，选自salvianolic acid B，其光学或几何异构体具有类似于salvianolic acid B的作用，其前药，药理学上允许的盐和上述化合物及其前药的水合物的化合物具有作用 以在保护神经干细胞或其分化的细胞的同时实现神经干细胞的增殖和/或分化。 该发现诱导了作用于神经细胞并且含有这些物质作为活性成分的药剂的开发，通过使用作用剂作用于​​神经细胞的方法，制备含神经细胞的液体的方法，并通过使用 作用方法，含有神经细胞的液体并通过使用制备方法制备，以及用于治疗引起的疾病的试剂 通过使用作用剂和/或含有神经细胞的液体作为活性成分的神经细胞变性。 版权所有（C）2006，JPO＆NCIPI

    Method for purifying moxidectin through crystallization
    6.
    发明专利
    Method for purifying moxidectin through crystallization 有权
    通过结晶来净化胶质细胞的方法

    公开(公告)号：JP2005053916A

    公开(公告)日：2005-03-03

    申请号：JP2004229533

    申请日：2004-08-05

    申请人： Wyeth ,  ワイスWyeth

    发明人： SOROKIN ISIDORO H ,  DI RAIMONDO PAOLA ,  CHOU CHIN-LIANG

    IPC分类号： C07D313/06 ,  A01N63/02 ,  A61K31/365 ,  A61P33/00 ,  A61P33/10 ,  A61P33/14 ,  C07D493/10 ,  C07D493/14 ,  C07D493/22 ,  C07H17/08

    CPC分类号： C07D493/22 ,  C07D493/10 ,  C07D493/14

    摘要： PROBLEM TO BE SOLVED: To provide a method whereby moxidectin is purified at a high cost efficiency without needing so long time and a high-purity final product is yielded.
    SOLUTION: A purification method for moxidectin comprises as follows: (a) moxidectin is dissolved in a first solvent to prepare a moxidectin solution; (b) the solution is concentrated at about 50°C or lower and then cooled to a temperature within a range of about 40-30°C; (c) a second solvent is added to the moxidectin solution; then, (d) the solution is stirred while the temperature is lowered into a range of about 30-10°C so as to precipitate moxidectin crystals from the moxidectin solution; (e) the crystals are filtered off from the solution; and (f) the crystals are dried.
    COPYRIGHT: (C)2005,JPO&NCIPI

    摘要翻译： 待解决的问题：提供一种方法，其中莫昔克丁以高成本效率纯化而不需要很长时间，并产生高纯度的最终产物。 解决方案：莫昔克丁的纯化方法包括如下：（a）将莫昔克丁溶于第一溶剂中以制备莫昔克丁溶液; （b）将溶液浓缩至约50℃或更低，然后冷却至约40-30℃范围内的温度; （c）将第二溶剂加入到莫昔克丁溶液中; 然后，（d）将溶液搅拌，同时将温度降低至约30-10℃的范围，以从莫昔克丁溶液中沉淀出莫昔克丁晶体; （e）从溶液中滤出晶体; 和（f）将晶体干燥。 版权所有（C）2005，JPO＆NCIPI